<DOC>
	<DOCNO>NCT00641459</DOCNO>
	<brief_summary>The purpose observational study obtain current status patient Behavioral Psychological Symptoms Dementia . This study also expect provide insight evolution behavioral psychotic symptom relationship treatment well severity cognitive decline naturalistic setting .</brief_summary>
	<brief_title>A Study Behavioral Psychological Symptoms Dementia</brief_title>
	<detailed_description>This observational , prospective , multi-center study obtain information symptom treatment receive patient behavioral psychological symptom dementia ( BPSD ) . Patients must first meet eligibility criterion sign inform consent . Patient treatment base upon investigator opinion . The following parameter assess : patient 's characteristic , Clinical Global Impression ( CGI ) score , Neuropsychiatric Inventory ( NPI ) , Minimal Mental Status Examination ( MMSE ) . Each patient observe 12 week . Medication dose regimen flexible throughout study base patient response investigator judgment . During study observation period , patient attend clinic visit subsequent 12 week ( visit 2 3 ) usual clinical practice . Patients visit clinic additional date need request . At pre-planned clinic visit , CGI score , NPI , vital sign , report adverse event , drug information , MMSE score ( visit 3 ) record . This observational study study drug administer .</detailed_description>
	<mesh_term>Dementia</mesh_term>
	<criteria>Patients diagnosis dementia accord DSMIV ( Diagnostic Statistical Manual Mental Disorders , Fourth Edition ) criterion Patients meet one follow type Dementia : Dementia Alzheimer 's Type ( AD ) , Vascular Dementia ( VaD ) , Dementia Lewy Body ( DLB ) , Parkinson 's Disease Dementia ( PDD ) Patients one active symptom Behavioral Psychological Symptoms Dementia ( BPSD ) Neuropsychiatric Inventory ( NPI ) receive treatment antipsychotic , mood stabilizer , antidepressant within 1 month prior study entry Patients caregiver ( ) give appropriate information patient assist assessment study Patients ( legally acceptable representative ) sign informed consent form Patients concurrent primary major psychiatric disorder ( Schizophrenia Bipolar disorder ) Patients history severe allergy multiple adverse drug reaction Patients history current symptom tardive dyskinesia Patients history neuroleptic malignant syndrome ( NMS ) Patients participate clinical trial investigational drug within 1 month ( 30 day ) prior study entry</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Behavioral Psychological Symptoms Dementia</keyword>
	<keyword>BPSD</keyword>
	<keyword>NPI</keyword>
	<keyword>CGI</keyword>
	<keyword>MMSE</keyword>
</DOC>